UKPEPTIDESRESEARCH & INFORMATION
CJC1295 with DAC 2mg

CJC1295 with DAC 2mg

£21.95

2mg lyophilised peptide powder Purity ≥98% — HPLC & MS verified cGMP certified Long-acting GHRH analogue with albumin-binding DAC For in vitro research use only

SKU: P004

Description

About CJC-1295 with DAC

CJC-1295 with DAC is a long-acting synthetic analogue of GHRH incorporating a Drug Affinity Complex (DAC) modification that enables covalent albumin binding, significantly extending the peptide’s plasma half-life. CJC-1295 with DAC has a molecular formula of C165H269N47O46 and a molecular weight of 3647.10 g/mol.

CJC-1295 with DAC is used in in vitro preclinical research investigating long-acting GHRHR agonism and albumin-binding pharmacokinetics.

CJC-1295 with DAC Peptide Specifications

  • Product Name: CJC1295 with DAC 2mg
  • Molecular Formula: C165H269N47O46
  • Molecular Weight: 3647.10 g/mol
  • Purity: ≥98% — HPLC and MS-UPLC verified
  • Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg(DAC)-NH₂
  • Form: Lyophilised solid
  • Certification: cGMP and ISO9001 compliant manufacturing

 

Storage and Reconstitution

CJC1295 with DAC 2mg is supplied in lyophilised solid form for optimal stability in research settings. Vials are stored in a monitored, temperature-controlled environment to maintain integrity prior to dispatch.

For reconstitution and storage guidance, refer to our peptide reconstitution instructions and peptide storage instructions. We recommend our Bacteriostatic Mixing Solution for reconstitution.

All PeptidesUK products are sold strictly for in vitro research purposes only and are not intended for human consumption.